S-Nitrosylation in Tumor Microenvironment

Vandana Sharma1, Veani Fernando1, Joshua Letson1

  • 1Department of Cancer Biology, University of Toledo Health Science Campus, 3000 Arlington Ave., Toledo, OH 43614, USA.

Insights

S-nitrosylation, a modification by nitric oxide (NO), impacts protein function and cellular signaling. This review explores its role in the tumor microenvironment (TME) and potential cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Biology

Background:

  • S-nitrosylation is a reversible post-translational modification of protein thiols by nitric oxide (NO).
  • It modulates protein conformation, activity, stability, and interactions, propagating NO signals.
  • S-nitrosylation influences both tumor suppression and promotion, impacting cancer progression.

Purpose of the Study:

  • To review the effects of S-nitrosylation on cells within the tumor microenvironment (TME).
  • To discuss the context-dependent outcomes of S-nitrosylation in the TME.
  • To explore therapeutic strategies targeting S-nitrosylation in cancer.

Main Methods:

  • Literature review of S-nitrosylation in cancer biology.
  • Analysis of S-nitrosylation's role in tumor microenvironment regulation.
  • Examination of therapeutic interventions modulating S-nitrosylation.

Main Results:

  • S-nitrosylation is a key regulator of the TME.
  • Its effects on TME cells are diverse and context-dependent.
  • Modulating S-nitrosylation shows therapeutic potential in cancer treatment.

Conclusions:

  • S-nitrosylation significantly impacts the TME and cancer pathogenesis.
  • Targeting S-nitrosylation offers promising avenues for cancer therapy.
  • Further research is needed to fully elucidate context-dependent effects for optimized treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
2° Amines to N-Nitrosamines: Reaction with NaNO201:20

2° Amines to N-Nitrosamines: Reaction with NaNO2

Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K